Literature DB >> 7874167

Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.

M Tassabehji1, V E Newton, A P Read.   

Abstract

Waardenburg syndrome type 2 (WS2) is a dominantly inherited syndrome of hearing loss and pigmentary disturbances. We recently mapped a WS2 gene to chromosome 3p12.3-p14.1 and proposed as a candidate gene MITF, the human homologue of the mouse microphthalmia (mi) gene. This encodes a putative basic-helix-loop-helix-leucine zipper transcription factor expressed in adult skin and in embryonic retina, otic vesicle and hair follicles. Mice carrying mi mutations show reduced pigmentation of the eyes and coat, and with some alleles, microphthalmia, hearing loss, osteopetrosis and mast cell defects. Here we show that affected individuals in two WS2 families have mutations affecting splice sites in the MITF gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874167     DOI: 10.1038/ng1194-251

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  138 in total

1.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Authors:  M Wu; T J Hemesath; C M Takemoto; M A Horstmann; A G Wells; E R Price; D Z Fisher; D E Fisher
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 2.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

Review 3.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

4.  Interspecies difference in the regulation of melanocyte development by SOX10 and MITF.

Authors:  Ling Hou; Heinz Arnheiter; William J Pavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

5.  Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

Authors:  Hideki Murakami; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-08

Review 6.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

7.  Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A.

Authors:  Y Nobukuni; A Watanabe; K Takeda; H Skarka; M Tachibana
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

8.  Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Authors:  Nadege Bondurand; Florence Dastot-Le Moal; Laure Stanchina; Nathalie Collot; Viviane Baral; Sandrine Marlin; Tania Attie-Bitach; Irina Giurgea; Laurent Skopinski; William Reardon; Annick Toutain; Pierre Sarda; Anis Echaieb; Marilyn Lackmy-Port-Lis; Renaud Touraine; Jeanne Amiel; Michel Goossens; Veronique Pingault
Journal:  Am J Hum Genet       Date:  2007-10-22       Impact factor: 11.025

9.  Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.

Authors:  S Carreira; T J Dexter; U Yavuzer; D J Easty; C R Goding
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family.

Authors:  M B McCormick; R M Tamimi; L Snider; A Asakura; D Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.